Jpmorgan Chase & CO Ishares Tr Genomics Immunology Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,964 shares of IDNA stock, worth $48,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,964
Previous 340 477.65%
Holding current value
$48,118
Previous $8,000 462.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$21.71 - $24.69 $35,257 - $40,096
1,624 Added 477.65%
1,964 $45,000
Q1 2024

May 10, 2024
BUY
$22.28 - $25.2 $7,575 - $8,568
340 New
340 $8,000
Q3 2023

Nov 14, 2023
BUY
$20.35 - $24.44 $407 - $488
20 New
20 $0
Q1 2023

May 11, 2023
SELL
$22.48 - $27.9 $606 - $753
-27 Reduced 58.7%
19 $0
Q4 2022

Feb 13, 2023
BUY
$24.22 - $29.01 $1,114 - $1,334
46 New
46 $1,000

Others Institutions Holding IDNA

# of Institutions
65
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email